Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

REGISTER for free or LOG IN to view this content

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Coronary

Presentation

TCT 2019

ACS/AMI

Up Next

Presentation TCT 2019

No Reflow: How to Prevent It and How to Fix It!

Presenter: Mitul Patel

September 26, 2019

More slides +

Presentation TCT 2019

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Presenter: Navin Kapur

September 26, 2019

Presentation TCT 2019

Utility of Coronary Physiology Assessment in the Asymptomatic Patient

Presenter: Stephane Fournier

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.